<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress/2.0.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>Bio Screening Industry News</title>
	<link>http://www.bioscreening.net</link>
	<description>Selected Bio Screening news, events and internet recources.</description>
	<pubDate>Tue, 02 Sep 2008 15:44:13 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.0.2</generator>
	<language>en</language>
			<item>
		<title>Lipinski Rule-of-Five</title>
		<link>http://www.bioscreening.net/glossary/lipinski-rule-of-five/</link>
		<comments>http://www.bioscreening.net/glossary/lipinski-rule-of-five/#comments</comments>
		<pubDate>Thu, 05 May 2005 00:47:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
	<category>North America</category>
		<guid isPermaLink="false">http://www.bioscreening.net/lipinski-rule-of-five/</guid>
		<description><![CDATA[Lipinski&#8217;s rule-of-five analysis
Christopher Lipinski&#8217;s rule-of-five analysis helped to raise awareness about properties and structural features that make molecules more or less drug-like. The guidelines were quickly adopted by the pharmaceutical industry as it helped apply ADME considerations early in preclinical development and could help avoid costly late-stage preclinical and clinical failures. The guidelines predict that [...]]]></description>
			<content:encoded><![CDATA[<p><strong>Lipinski&#8217;s rule-of-five analysis</strong><br />
Christopher Lipinski&#8217;s rule-of-five analysis helped to raise awareness about properties and structural features that make molecules more or less drug-like. The guidelines were quickly adopted by the pharmaceutical industry as it helped apply ADME considerations early in preclinical development and could help avoid costly late-stage preclinical and clinical failures. The guidelines predict that poor absorption or permeation of a orally administered compound are more likely if the compound meets the following criteria:</p>
<p>    * Molecular mass greater than 500 Da<br />
    * High lipophilicity (expressed as cLogP greater than 5)<br />
    * More than 5 hydrogen bond donors<br />
    * More than 10 hydrogen bond acceptors
</p>
]]></content:encoded>
			<wfw:commentRSS>http://www.bioscreening.net/glossary/lipinski-rule-of-five/feed/</wfw:commentRSS>
		</item>
	</channel>
</rss>
